REIMBURSEMENT News
Most Popular REIMBURSEMENT Story
Dendreon demonstrates tougher commercialization hurdles for developers
It takes years in biotechnology to forge an enduring success. But failure is always just one false step away. Look at Dendreon ($DNDN). A little more than a year ago, the biotech pioneer was Read more...
Latest Headlines
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
